These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
222 related articles for article (PubMed ID: 29028800)
21. Extensively drug-resistant tuberculosis in women, KwaZulu-Natal, South Africa. O'Donnell MR; Zelnick J; Werner L; Master I; Loveday M; Horsburgh CR; Padayatchi N Emerg Infect Dis; 2011 Oct; 17(10):1942-5. PubMed ID: 22000378 [TBL] [Abstract][Full Text] [Related]
22. Averting epidemics of extensively drug-resistant tuberculosis. Basu S; Friedland GH; Medlock J; Andrews JR; Shah NS; Gandhi NR; Moll A; Moodley P; Sturm AW; Galvani AP Proc Natl Acad Sci U S A; 2009 May; 106(18):7672-7. PubMed ID: 19365076 [TBL] [Abstract][Full Text] [Related]
23. A historical review of XDR tuberculosis in the Western Cape province of South Africa. Symons G; Shean K; Pietersen E; Van Zyl Smit R; Pool L; Davids M; Willcox P; Dheda K S Afr Med J; 2011 Sep; 101(9):636-8. PubMed ID: 21920174 [TBL] [Abstract][Full Text] [Related]
24. Provider perspectives on drug-resistant tuberculosis and human immunodeficiency virus care in South Africa: a qualitative case study. Daftary A; Padayatchi N Int J Tuberc Lung Dis; 2016 Nov; 20(11):1483-1488. PubMed ID: 27776589 [TBL] [Abstract][Full Text] [Related]
25. Modeling Missing Cases and Transmission Links in Networks of Extensively Drug-Resistant Tuberculosis in KwaZulu-Natal, South Africa. Nelson KN; Gandhi NR; Mathema B; Lopman BA; Brust JCM; Auld SC; Ismail N; Omar SV; Brown TS; Allana S; Campbell A; Moodley P; Mlisana K; Shah NS; Jenness SM Am J Epidemiol; 2020 Jul; 189(7):735-745. PubMed ID: 32242216 [TBL] [Abstract][Full Text] [Related]
26. Evolving rifampicin and isoniazid mono-resistance in a high multidrug-resistant and extensively drug-resistant tuberculosis region: a retrospective data analysis. Mvelase NR; Balakrishna Y; Lutchminarain K; Mlisana K BMJ Open; 2019 Nov; 9(11):e031663. PubMed ID: 31699736 [TBL] [Abstract][Full Text] [Related]
27. A health systems assessment of the KwaZulu-Natal tuberculosis programme in the context of increasing drug resistance. Loveday M; Thomson L; Chopra M; Ndlela Z Int J Tuberc Lung Dis; 2008 Sep; 12(9):1042-7. PubMed ID: 18713502 [TBL] [Abstract][Full Text] [Related]
29. Assessing Local Risk of Rifampicin-Resistant Tuberculosis in KwaZulu-Natal, South Africa Using Lot Quality Assurance Sampling. Heidebrecht CL; Podewils LJ; Pym A; Mthiyane T; Cohen T PLoS One; 2016; 11(4):e0153143. PubMed ID: 27050561 [TBL] [Abstract][Full Text] [Related]
30. Prevalence of delay in seeking tuberculosis care and the health care seeking behaviour profile of tuberculous patients in a rural district of KwaZulu Natal, South Africa. Chiposi L; Cele LP; Mokgatle M Pan Afr Med J; 2021; 39():27. PubMed ID: 34394818 [TBL] [Abstract][Full Text] [Related]
31. Treatment outcomes of pre- and extensively drug-resistant tuberculosis in Johannesburg, South Africa. Nkurunziza J; Karstaedt AS; Louw R; Padanilam X Int J Tuberc Lung Dis; 2018 Dec; 22(12):1469-1474. PubMed ID: 30606319 [TBL] [Abstract][Full Text] [Related]
32. Emergence and treatment of multidrug resistant (MDR) and extensively drug-resistant (XDR) tuberculosis in South Africa. Streicher EM; Müller B; Chihota V; Mlambo C; Tait M; Pillay M; Trollip A; Hoek KG; Sirgel FA; Gey van Pittius NC; van Helden PD; Victor TC; Warren RM Infect Genet Evol; 2012 Jun; 12(4):686-94. PubMed ID: 21839855 [TBL] [Abstract][Full Text] [Related]
33. Multidrug-resistant and extensively drug-resistant tuberculosis: implications for the HIV epidemic and antiretroviral therapy rollout in South Africa. Andrews JR; Shah NS; Gandhi N; Moll T; Friedland G; J Infect Dis; 2007 Dec; 196 Suppl 3():S482-90. PubMed ID: 18181698 [TBL] [Abstract][Full Text] [Related]
34. Representations of MDR and XDR-TB in South African newspapers. Daku M; Gibbs A; Heymann J Soc Sci Med; 2012 Jul; 75(2):410-8. PubMed ID: 22534376 [TBL] [Abstract][Full Text] [Related]
35. The impact of COVID-19 national lockdowns on drug-resistant tuberculosis in KwaZulu-Natal, South Africa: A spatial analysis. Harrington KRV; Gandhi NR; Shah NS; Naidoo K; Auld SC; Andrews JR; Brust JCM; Lutchminarain K; Coe M; Willis F; Campbell A; Cohen T; Jenness SM; Waller LA; Ann Epidemiol; 2024 Sep; 97():44-51. PubMed ID: 39038747 [TBL] [Abstract][Full Text] [Related]
36. Evolution of the extensively drug-resistant F15/LAM4/KZN strain of Mycobacterium tuberculosis in KwaZulu-Natal, South Africa. Pillay M; Sturm AW Clin Infect Dis; 2007 Dec; 45(11):1409-14. PubMed ID: 17990220 [TBL] [Abstract][Full Text] [Related]
37. Spatial Distribution of Cancer Cases Seen in Three Major Public Hospitals in KwaZulu-Natal, South Africa. Motlana MK; Ginindza TG; Mitku AA; Jafta N Cancer Inform; 2021; 20():11769351211028194. PubMed ID: 34285460 [TBL] [Abstract][Full Text] [Related]
38. HIV coinfection in multidrug- and extensively drug-resistant tuberculosis results in high early mortality. Gandhi NR; Shah NS; Andrews JR; Vella V; Moll AP; Scott M; Weissman D; Marra C; Lalloo UG; Friedland GH; Am J Respir Crit Care Med; 2010 Jan; 181(1):80-6. PubMed ID: 19833824 [TBL] [Abstract][Full Text] [Related]
39. TB in health care workers in KwaZulu-Natal, South Africa. Naidoo S; Jinabhai CC Int J Tuberc Lung Dis; 2006 Jun; 10(6):676-82. PubMed ID: 16776456 [TBL] [Abstract][Full Text] [Related]
40. Extensively drug-resistant tuberculosis as a cause of death in patients co-infected with tuberculosis and HIV in a rural area of South Africa. Gandhi NR; Moll A; Sturm AW; Pawinski R; Govender T; Lalloo U; Zeller K; Andrews J; Friedland G Lancet; 2006 Nov; 368(9547):1575-80. PubMed ID: 17084757 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]